Drug Database
Back to search

Netherlands· NL-fe4fa8697d22

Alhemo 15 mg/1,5 ml oplossing voor injectie in een voorgevulde pen

A concizumab product containing concizumab, registered in Netherlands by Novo Nordisk A.S.. The same ATC class is registered in 11 of our 19 countries.

ATC B02BX10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAlhemo 15 mg/1,5 ml oplossing voor in…ATCB02BX10REGISTER NO.NL-fe4fa8697d22PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about concizumabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Concizumab is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BX10 (concizumab), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search concizumab products by name

Concizumab · ATC B02BX10

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of concizumab costs, country by country.

Normalised to the WHO defined daily dose (14 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Concizumab · price per daily dose (14 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1227.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CONCIZUMAB
Manufacturer
Novo Nordisk A.S.
Country
Netherlands (NL)
ATC code
B02BX10
ATC class
Concizumab
Defined daily dose
14 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1881

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Concizumab in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All concizumab products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Alhemo
  • Norway · Alhemo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9d343fc0-c55a-42ea-bf1b-ea061c57ef1b
GET /v1/drugs/9d343fc0-c55a-42ea-bf1b-ea061c57ef1b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/alhemo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Concizumab",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131038",
  "excipients": [
    "ARGININEHYDROCHLORIDE, (L-)",
    "FENOL",
    "HISTIDINE, (L-)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "CONCIZUMAB"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/12/13",
  "procedure_number": "EMEA/H/C/005938",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1881",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about concizumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console